Pacira BioSciences (PCRX) EPS (Basic) Growth (1y) (2011 - 2026)
Pacira BioSciences (PCRX) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Pacira BioSciences | 970.37 Mn | 719.34 Mn | 148.24 Mn | 210.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 210.59% |
| Mar 31, 2026 | -30.69% |
| Dec 31, 2025 | -89.41% |
| Sep 30, 2025 | 103.97% |
| Jun 30, 2025 | -126.07% |
| Mar 31, 2025 | -46.15% |
| Dec 31, 2024 | -35.53% |
| Sep 30, 2024 | -1,429.37% |
| Jun 30, 2024 | -26.83% |
| Mar 31, 2024 | 145.42% |
| Dec 31, 2023 | 342.46% |
| Sep 30, 2023 | 1,647.06% |
| Jun 30, 2023 | 27.97% |
| Mar 31, 2023 | -379.39% |
| Dec 31, 2022 | -91.47% |
| Sep 30, 2022 | -103.81% |
| Jun 30, 2022 | 1.06% |
| Mar 31, 2022 | -35.39% |
| Dec 31, 2021 | -134.04% |
| Sep 30, 2021 | 2,563.20% |